Real-world evidence shows Pluvicto matches pivotal trial benefits in PSMA-positive mCRPC, with longer PFS after one ARPI and delayed chemotherapy.

Recursion Pharmaceuticals Inc (RXRX) showcases strong financial management and strategic partnerships while navigating challenges in drug discovery.

Guidance extended from year-end 2027 to early 2028, with operating expense reduction targets reiterated and achieved at a greater scale (now 35% year-over-year, 10% below guidance). Strategic focus ...

Totaligent (OTCID: TGNT) announced the execution of a binding Letter of Intent (LOI) with GloMed Solutions Limited Liability Company, a Japanese medical aesthetics and biologics distributor, to form a ...

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple clinica ...

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological ...

Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...

Bad Bunny’s Super Bowl halftime show continues to live rent-free in the minds of Republican lawmakers and conservative commentators. Plenty of right-wingers were outraged that the NFL tapped the ...

Several celebrities, including Chappell Roan and Orville Peck, have come forward to condemn and cut ties with Casey Wasserman, the founder and CEO of sports marketing and talent agency Wassermany ...

Atlantic.net offers an excellent range of unmanaged hosting plans, with the option to add-on expert managed services.

Karandeep Singh Oberoi is a Durham College Journalism and Mass Media graduate who joined the Android Police team in April 2024, after serving as a full-time News Writer at Canadian publication ...

Is On Investors’ Radar Today Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt ...